Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19717184 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome
Condition: Coronary Disease
Interventions: Drug: Otamixaban (XRP0673);   Drug: unfractionated heparin;   Drug: eptifibatide

Indicates status has not been verified in more than two years